Wikidata entity: Q407988
C₁₅H₁₀ClN₃O₃ (P274)
Quantities
| P4250 | defined daily dose | 8 |
| P2067 | mass | 315.041 |
| P3780 | active ingredient in | ... | Q47521744 (Klonopin) | Klonopin |
| P233 | canonical SMILES | String | C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3Cl | ??? |
| P373 | Commons category | String | Clonazepam | ??? |
| P1343 | described by source | ... | Q316572 (Opium Law) | Opium Law |
| P1889 | different from | ... | Q221361 (clozapine) | clozapine |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P3493 | legal status (medicine) | ... | Q879952 (boxed warning) | boxed warning |
| P8026 | LiverTox likelihood score | ... | Q83284515 (LiverTox toxicity likelihood category D) | LiverTox toxicity likelihood category D |
| P1987 | MCN code | String | 2933.91.13 | ??? |
| P2175 | medical condition treated | ... | Q41112 (schizophrenia) | schizophrenia |
| P2175 | medical condition treated | ... | Q41571 (epilepsy) | epilepsy |
| P2175 | medical condition treated | ... | Q131755 (bipolar disorder) | bipolar disorder |
| P2175 | medical condition treated | ... | Q154430 (anxiety) | anxiety |
| P2175 | medical condition treated | ... | Q202387 (post-traumatic stress disorder) | post-traumatic stress disorder |
| P2175 | medical condition treated | ... | Q225957 (dysarthria) | dysarthria |
| P2175 | medical condition treated | ... | Q544006 (anxiety disorder) | anxiety disorder |
| P2175 | medical condition treated | ... | Q741713 (panic disorder) | panic disorder |
| P2175 | medical condition treated | ... | Q845224 (generalized anxiety disorder) | generalized anxiety disorder |
| P2175 | medical condition treated | ... | Q916280 (restless legs syndrome) | restless legs syndrome |
| P2175 | medical condition treated | ... | Q1869874 (insomnia) | insomnia |
| P2175 | medical condition treated | ... | Q2184304 (transient tic disorder) | transient tic disorder |
| P2175 | medical condition treated | ... | Q2894827 (childhood absence epilepsy) | childhood absence epilepsy |
| P2175 | medical condition treated | ... | Q5326887 (early myoclonic encephalopathy) | early myoclonic encephalopathy |
| P2175 | medical condition treated | ... | Q11883686 (myoclonic epilepsy) | myoclonic epilepsy |
| P2175 | medical condition treated | ... | Q54972453 (sleep-wake disorder) | sleep-wake disorder |
| P129 | physically interacts with | ... | Q5520260 (Gamma-aminobutyric acid type A receptor subunit alpha1) | Gamma-aminobutyric acid type A receptor subunit alpha1 |
| P129 | physically interacts with | ... | Q21114578 (Gamma-aminobutyric acid type A receptor subunit alpha3) | Gamma-aminobutyric acid type A receptor subunit alpha3 |
| P129 | physically interacts with | ... | Q21114582 (Gamma-aminobutyric acid type A receptor subunit alpha2) | Gamma-aminobutyric acid type A receptor subunit alpha2 |
| P3489 | pregnancy category | ... | Q3679261 (Australian pregnancy category C) | Australian pregnancy category C |
| P3489 | pregnancy category | ... | Q28123618 (US pregnancy category D) | US pregnancy category D |
| P769 | significant drug interaction | ... | Q81225 (morphine) | morphine |
| P769 | significant drug interaction | ... | Q55434 (pethidine) | pethidine |
| P769 | significant drug interaction | ... | Q58614 (loxapine) | loxapine |
| P769 | significant drug interaction | ... | Q179996 ((RS)-methadone) | (RS)-methadone |
| P769 | significant drug interaction | ... | Q303646 (hydromorphone) | hydromorphone |
| P769 | significant drug interaction | ... | Q407535 (oxycodone) | oxycodone |
| P769 | significant drug interaction | ... | Q407541 (fentanyl) | fentanyl |
| P769 | significant drug interaction | ... | Q377270 (dihydrocodeine) | dihydrocodeine |
| P769 | significant drug interaction | ... | Q407241 (phenobarbital) | phenobarbital |
| P769 | significant drug interaction | ... | Q407592 (tramadol) | tramadol |
| P769 | significant drug interaction | ... | Q407721 (buprenorphine) | buprenorphine |
| P769 | significant drug interaction | ... | Q174723 (codeine) | codeine |
| P769 | significant drug interaction | ... | Q176533 (alfentanil) | alfentanil |
| P769 | significant drug interaction | ... | Q421930 (mirtazapine) | mirtazapine |
| P769 | significant drug interaction | ... | Q414463 (tapentadol) | tapentadol |
| P769 | significant drug interaction | ... | Q417915 (sufentanil) | sufentanil |
| P769 | significant drug interaction | ... | Q420383 (primidone) | primidone |
| P769 | significant drug interaction | ... | Q2622907 (periciazine) | periciazine |
| P769 | significant drug interaction | ... | Q7553347 (sodium oxybate) | sodium oxybate |
| P769 | significant drug interaction | ... | Q55186498 ((±)-thiopental) | (±)-thiopental |
| P9989 | stylized name | String | clonazePAM | ??? |
| P9989 | stylized name | String | KlonoPIN | ??? |
| P279 | subclass of | ... | Q83871 (benzodiazepine drug) | benzodiazepine drug |
| P2868 | subject has role | ... | Q576618 (anticonvulsant agent) | anticonvulsant agent |
| P2868 | subject has role | ... | Q17164853 (GABAA receptor positive allosteric modulators) | GABAA receptor positive allosteric modulators |
| P2868 | subject has role | ... | Q50430260 (GABA Modulators) | GABA Modulators |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | clonazepam | ??? |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | klonazepam | ??? |
| P267 | ATC code | N03AE01 |
| P231 | CAS Registry Number | 1622-61-3 |
| P683 | ChEBI ID | 3756 |
| P592 | ChEMBL ID | CHEMBL452 |
| P661 | ChemSpider ID | 2700 |
| P715 | DrugBank ID | DB01068 |
| P11198 | DrugCentral ID | 703 |
| P8494 | DSSTOX compound identifier | DTXCID002845 |
| P3117 | DSSTox substance ID | DTXSID1022845 |
| P232 | EC number | 216-596-2 |
| P2566 | ECHA Substance Infocard ID | 100.015.088 |
| P9635 | electronic Essential Medicines List medicine ID | 449 |
| P646 | Freebase ID | /m/035wxl |
| P12385 | Gran Enciclopèdia Catalana ID | clonazepam |
| P1296 | Gran Enciclopèdia Catalana ID (former scheme) | 0091251 |
| P595 | Guide to Pharmacology Ligand ID | 6963 |
| P2062 | HSDB ID | 3265 |
| P2057 | Human Metabolome Database ID | HMDB0015201 |
| P234 | InChI | InChI=1S/C15H10ClN3O3/c16-12-4-2-1-3-10(12)15-11-7-9(19(21)22)5-6-13(11)18-14(20)8-17-15/h1-7H,8H2,(H,18,20) |
| P235 | InChIKey | DGBIGWXXNGSACT-UHFFFAOYSA-N |
| P8408 | KBpedia ID | Clonazepam |
| P665 | KEGG ID | D00280 |
| P244 | Library of Congress authority ID | sh93005964 |
| P7830 | LiverTox ID | Clonazepam |
| P6689 | MassBank accession ID | MSBNK-Waters-WA002949 |
| P6689 | MassBank accession ID | MSBNK-Waters-WA002950 |
| P6689 | MassBank accession ID | MSBNK-Waters-WA002951 |
| P6689 | MassBank accession ID | MSBNK-Waters-WA002952 |
| P6689 | MassBank accession ID | MSBNK-Waters-WA002953 |
| P6689 | MassBank accession ID | MSBNK-Waters-WA002954 |
| P10245 | MedlinePlus drug identifier | a682279 |
| P6694 | MeSH concept ID | M0004601 |
| P486 | MeSH descriptor ID | D002998 |
| P672 | MeSH tree code | D03.633.100.079.080.070.150 |
| P6366 | Microsoft Academic ID (discontinued) | 2779426884 |
| P8189 | National Library of Israel J9U ID | 987007537060505171 |
| P2115 | NDF-RT ID | N0000146152 |
| P9405 | NMRShiftDB structure ID | 20237370 |
| P2840 | NSC number | 179913 |
| P10283 | OpenAlex ID | C2779426884 |
| P4235 | PatientsLikeMe treatment ID | clonazepam |
| P11199 | Probes And Drugs ID | PD009568 |
| P662 | PubChem CID | 2802 |
| P3417 | Quora topic ID | Clonazepam |
| P1579 | Reaxys registry number | 759557 |
| P3345 | RxNorm CUI | 2598 |
| P4964 | SPLASH | splash10-02a9-2492000000-109e2626e8a128b9e433 |
| P2877 | SureChEMBL ID | 38899 |
| P2892 | UMLS CUI | C0009011 |
| P11089 | UniChem compound ID | 450374 |
| P652 | UNII | 5PE9FDE8GB |
| P11143 | WikiProjectMed ID | Clonazepam |
Why not click here or view trends?
log id: None